Related Experiment Video
Updated: Jun 8, 2026
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Recombinant human myeloperoxidase from Pichia pastoris: Functional analyses and potential for surface applications
Parfait Kenfack Ymbe1, Victoria Lublin1, Aenora Letourneur1
1CNRS, University of Bordeaux, CRPP, UMR5031, 115 Avenue Schweitzer, Pessac F-33600, France.
Abstract:
Human myeloperoxidase (hMPO) catalyzes the conversion of hydrogen peroxide and chloride into hypochlorous acid and plays a key role in human immunity. While commercial MPO is typically purified from human blood or produced recombinantly in mammalian cells or E. coli, we present novel approach for producing active recombinant hMPO (rhMPO) in Pichia pastoris. To eliminate the need for enzyme coupling, we engineered a chimeric protein by combining glucose oxidase from Penicillium amagasakiense and rhMPO. The two open reading frames were fused by PCR, yielding a bifunctional enzyme capable of generating hypochlorous acid directly from glucose. Additionally, the enzymes were immobilized on silicone model substrates via adsorption from solution to generate surface activity. This yeast-based production system provides a cost-effective and scalable platform for large-scale MPO synthesis, opening the development of novel biocatalytic applications.
Insights
Researchers developed a novel method to produce active recombinant human myeloperoxidase (hMPO) in yeast. This cost-effective system creates a bifunctional enzyme for direct hypochlorous acid generation from glucose.
Area of Science:
- Biocatalysis and Enzyme Engineering
- Microbial Production Systems
- Biotechnology
Background:
- Human myeloperoxidase (hMPO) is crucial for immunity, converting hydrogen peroxide and chloride to hypochlorous acid.
- Current hMPO production methods involve purification from blood or recombinant expression in mammalian cells or E. coli, which can be costly and complex.
- There is a need for scalable and cost-effective production of active hMPO for various applications.
Purpose of the Study:
- To develop a novel, cost-effective, and scalable method for producing active recombinant human myeloperoxidase (rhMPO).
- To engineer a bifunctional enzyme combining glucose oxidase and rhMPO for direct hypochlorous acid generation from glucose.
- To immobilize the engineered enzyme onto silicone substrates for surface activity.
Main Methods:
- Recombinant production of active rhMPO in the yeast Pichia pastoris.
- Engineering a chimeric bifunctional enzyme by fusing glucose oxidase (from Penicillium amagasakiense) and rhMPO using PCR.
- Immobilization of the enzyme onto silicone model substrates via adsorption.
Main Results:
- Successful production of active rhMPO in Pichia pastoris, establishing a yeast-based expression system.
- Creation of a bifunctional enzyme capable of directly generating hypochlorous acid from glucose, eliminating the need for enzyme coupling.
- Demonstrated immobilization of the enzyme on silicone substrates, enabling surface-based biocatalysis.
Conclusions:
- Pichia pastoris offers a cost-effective and scalable platform for producing active rhMPO.
- The engineered bifunctional enzyme simplifies hypochlorous acid generation, enabling new biocatalytic applications.
- Surface-immobilized rhMPO expands the potential uses of this enzyme in various technological fields.
